Literature DB >> 35843683

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions.

Jung Il Lee1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35843683      PMCID： PMC9289830          DOI： 10.5009/gnl220276

Source DB:  PubMed          Journal:  Gut Liver        ISSN： 1976-2283            Impact factor:   4.321


× No keyword cloud information.
  11 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  F Schaffner; H Thaler
Journal:  Prog Liver Dis       Date:  1986

Review 2.  MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

Authors:  Mohammed Eslam; Arun J Sanyal; Jacob George
Journal:  Gastroenterology       Date:  2020-02-08       Impact factor: 22.682

3.  Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.

Authors:  Hokyou Lee; Yong-Ho Lee; Seung Up Kim; Hyeon Chang Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-22       Impact factor: 11.382

4.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.

Authors:  Zobair M Younossi; Deirdre Blissett; Robert Blissett; Linda Henry; Maria Stepanova; Youssef Younossi; Andrei Racila; Sharon Hunt; Rachel Beckerman
Journal:  Hepatology       Date:  2016-09-26       Impact factor: 17.425

5.  Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Jean Woo; Jill M Abrigo; Carmen Ka-Man Chan; Sally She-Ting Shu; Julie Ka-Yu Leung; Angel Mei-Ling Chim; Alice Pik-Shan Kong; Grace Chung-Yan Lui; Henry Lik-Yuen Chan; Winnie Chiu-Wing Chu
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-31       Impact factor: 11.382

6.  Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease.

Authors:  Shang-Chin Huang; Hau-Jyun Su; Jia-Horng Kao; Tai-Chung Tseng; Hung-Chih Yang; Tung-Hung Su; Pei-Jer Chen; Chun-Jen Liu
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

7.  Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.

Authors:  Donghee Kim; Peter Konyn; Keeryth K Sandhu; Brittany B Dennis; Amanda C Cheung; Aijaz Ahmed
Journal:  J Hepatol       Date:  2021-08-08       Impact factor: 30.083

8.  Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.

Authors:  Myriam Alexander; A Katrina Loomis; Johan van der Lei; Talita Duarte-Salles; Daniel Prieto-Alhambra; David Ansell; Alessandro Pasqua; Francesco Lapi; Peter Rijnbeek; Mees Mosseveld; Paul Avillach; Peter Egger; Nafeesa N Dhalwani; Stuart Kendrick; Carlos Celis-Morales; Dawn M Waterworth; William Alazawi; Naveed Sattar
Journal:  BMJ       Date:  2019-10-08

9.  Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease.

Authors:  Seogsong Jeong; Yun Hwan Oh; Seulggie Choi; Jooyoung Chang; Sung Min Kim; Joung Sik Son; Gyeongsil Lee; Won Kim; Sang Min Park
Journal:  Gut Liver       Date:  2021-11-03       Impact factor: 4.321

10.  KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.

Authors:  Seong Hee Kang; Hye Won Lee; Jeong-Ju Yoo; Yuri Cho; Seung Up Kim; Tae Hee Lee; Byoung Kuk Jang; Sang Gyune Kim; Sang Bong Ahn; Haeryoung Kim; Dae Won Jun; Joon-Il Choi; Do Seon Song; Won Kim; Soung Won Jeong; Moon Young Kim; Hong Koh; Sujin Jeong; Jin-Woo Lee; Yong Kyun Cho
Journal:  Clin Mol Hepatol       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.